Cargando…
Open-label placebos as adjunctive therapy for patients with depression
BACKGROUND: Placebos prescribed as ‘regular’ medication can reduce symptoms of depression. However, using a placebo without patients' informed consent presents ethical issues. Therefore, the present study assessed the efficacy of an open-label placebo (OLP), which was administered concurrently...
Autores principales: | Schienle, Anne, Jurinec, Nina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9228278/ https://www.ncbi.nlm.nih.gov/pubmed/35754973 http://dx.doi.org/10.1016/j.conctc.2022.100948 |
Ejemplares similares
-
Combined Cognitive-Behavioral Therapy and Placebo Treatment for Patients with Depression: A Follow-Up Assessment
por: Schienle, Anne, et al.
Publicado: (2021) -
Placebo Effects on Visual Food Cue Reactivity: An Eye-Tracking Investigation
por: Potthoff, Jonas, et al.
Publicado: (2019) -
Changes in neural processing and evaluation of negative facial expressions after administration of an open-label placebo
por: Schienle, Anne, et al.
Publicado: (2022) -
Open-label placebo treatment to improve relaxation training effects in healthy psychology students: a randomized controlled trial
por: Schienle, Anne, et al.
Publicado: (2021) -
Open-label placebo treatment for reducing overeating in children: A study protocol for a randomized clinical trial with an app-assisted approach
por: Schienle, Anne, et al.
Publicado: (2023)